By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Pulmonx, Inc. 

1049 Elwell Court

Palo Alto  California  94303  U.S.A.
Phone: 650-934-2600 Fax: 650-934-2601


Medical Device

Start Up

Company News
Pulmonx, Inc. Release: New Data From Two Multi-Center Randomized Clinical Trials Demonstrate That Zephyr Endobronchial Valves Deliver Benefit To Both Heterogeneous And Homogenous Emphysema Patients Without Collateral Ventilation 5/24/2017 6:57:04 AM
Pulmonx, Inc. Completes Enrollment In U.S. Pivotal Trial Of Zephyr Endobronchial Valve 10/6/2016 10:04:38 AM
New Study Demonstrates Benefits Of Pulmonx, Inc. Zephyr Endobronchial Valve In Patients With Homogeneous Emphysema 9/6/2016 1:41:24 PM
STELVIO Trial Shows Sustained Benefits For Emphysema Patients One Year After Treatment With Pulmonx, Inc.'s Zephyr Endobronchial Valves 5/19/2016 11:49:48 AM
Pulmonary Experts Recommend Zephyr Endobronchial Valve (EBV) From Pulmonx, Inc. As Only Minimally-Invasive Emphysema Treatment To Be Used Outside Clinical Trials 3/10/2016 10:16:05 AM
Pulmonx, Inc. Completes Enrollment Of Randomized, Prospective, Multi-Center Study In New Patient Population 1/14/2016 8:50:32 AM
Pulmonx, Inc. Launches Chartis Tablet, Simplifying Patient Selection For Zephyr Endobronchial Valve Therapy 10/2/2015 1:42:00 PM
Lancet Publication Of Sham-Controlled Clinical Trial Shows Pulmonx, Inc.’s Zephyr Endobronchial Valves Deliver Significant Benefit To Emphysema Patients 7/1/2015 10:31:25 AM
Zephyr Endobronchial Valves From Pulmonx, Inc. Shown To Benefit Severe Emphysema Patients With Homogeneous Disease 5/18/2015 10:40:53 AM
Stelvio Trial Further Validates Positive Outcomes For Zephyr Endobronchial Valves From Pulmonx, Inc. 5/18/2015 10:03:11 AM